VYNE - VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q2 2021 Results - Earnings Call Transcript
VYNE Therapeutics Inc. (VYNE) Q2 2021 Earnings Conference Call August 12, 2021 08:30 AM ET Company Participants Chase Oswald - Investor Relations, LifeSci Advisors Dave Domzalski - President & Chief Executive Officer Tyler Zeronda - Chief Financial Officer Iain Stuart - Chief Scientific Officer Mutya Harsch - General Counsel & Chief Legal Officer Conference Call Participants Carvey Leung - Cantor Fitzgerald Ken Cacciatore - Cowen David Amsellem - Piper Sandler Patrick Dolezal - LifeSci Capital Oren Livnat – H.C. Wainwright Balaji Prasad - Barclays Presentation Operator Greetings and welcome to the VYNE Therapeutics Second Quarter 2021 Earnings Call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded Thursday, August 12, 2021. I would now like to turn the conference over to Chase Oswald from LifeSci Advisors. Please, go ahead. Chase Oswald
For further details see:
VYNE Therapeutics Inc. (VYNE) CEO Dave Domzalski on Q2 2021 Results - Earnings Call Transcript